Oric Pharmaceuticals, Inc. (ORIC)
Oric Pharmaceuticals, Inc. (ORIC) is a Healthcare stock tracked by StreetAlpha. ORIC reports earnings on Thu, Nov 12, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (6 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in ORIC, 0% of them bullish and 100% bearish.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 28 | BTIG | Reiterated | Buy | — |
| Oct 27 | Wedbush | Maintained | Buy | — |
| Oct 26 | Stifel | Maintained | Buy | — |
| Oct 14 | JP Morgan | Maintained | Buy | — |
| Oct 5 | Leerink Partners | Initiated | Buy | — |
Whale Options Flow
90DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ORIC is in one of them and how their past ORIC trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered ORIC in an article yet. Here's the latest on the wider market.